vaccines

TL/DR - The Inflation Reduction Act (IRA), signed into law in August 2022, has introduced several provisions affecting the pharmaceutical industry, particularly biosimilars. The IRA promotes adoption of biosimilars by increasing their reimbursement rate in Medicare Part B to 108% of Average Selling Price (ASP) for a 5-year period until December…